DENTSPLY SIRONA Insider Sales: CEO’s Tiny Tax‑Cover Trade Signals More Buying, Not Trouble

Insider Activity Highlights a Strategic Shift at DENTSPLY SIRONA

Executive Sales Amid a Steady Stock Trajectory On February 24, 2026, President, CEO, and Board Member Daniel Scavilla sold 1,194 shares of common stock at a price of $13.14—slightly below the close of $13.14 on the previous day. The sale, executed to cover tax obligations on vesting Restricted Stock Units, represents a modest 0.07 % of his outstanding holdings, bringing his post‑transaction stake to 16,750 shares. While the trade is small relative to his cumulative ownership, it aligns with the pattern of periodic “cover‑tax” sales that have punctuated Scavilla’s tenure.

Implications for Investors The timing of the sale—after a 1.84 % weekly gain and amidst a 25.8 % YTD decline—suggests a tactical move rather than a confidence signal. Investors should note that the trade occurs within a broader context of robust insider buying. Over the past 12 months, Scavilla has completed seven purchases of common stock, each for fewer than 1,000 shares, cumulatively adding roughly 1,800 shares to his position. These incremental buys, coupled with the company’s recent product launches and partnership expansions, reinforce a long‑term bullish stance.

What the Pattern Reveals About Scavilla Historically, Scavilla’s transactions have been characterized by:

1. Small, frequent purchases – typically 200–245 shares, reflecting a conservative accumulation strategy.
2. Cover‑tax sales – the February 24 sale is a repeat of the October 10, 2025 and January 9, 2026 tax‑cover trades.
3. Limited exposure to stock options – a single large option purchase in August 2025 (1,102,600 shares) was a vesting‑triggered award, not a market‑price trade.

These patterns indicate a prudent, long‑term approach, aligning his interests with shareholders while maintaining liquidity to manage tax liabilities.

Company‑Wide Insider Momentum Beyond Scavilla, other executives—including Vice President Kevin Czerney and Senior Vice President Robert Johnson—have executed significant purchases, reinforcing confidence in DENTSPLY SIRONA’s strategy. The board’s recent addition of finance‑savvy directors and the expanded distribution partnership with Burkhart Dental Supply further signal a governance and growth focus that insiders appear to endorse.

Takeaway for Market Participants Scavilla’s modest sale is a routine tax‑cover move and does not signal distress. Investors can interpret the continued buying by top management, combined with the company’s strategic initiatives, as evidence of a stable, growth‑oriented outlook. Monitoring future insider filings, especially larger option exercises or sell‑offs, will provide early warning of any shift in sentiment.